| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.016 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |